Dengue Therapeutics, Chemoprophylaxis, and Allied Tools: State of the Art and Future Directions
Dengue is the most common arboviral disease of humans. There is an unmet need for a therapeutic intervention that reduces the duration and severity of dengue symptoms and diminishes the likelihood of severe complications. To this end, there are active discovery efforts in industry and academia to de...
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Journal Article |
| Lenguaje: | inglés |
| Publicado: |
2018
|
| Acceso en línea: | https://demo7.dspace.org/handle/123456789/82 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Dengue Therapeutics, Chemoprophylaxis, and Allied Tools: State of the Art and Future Directions
- Therapeutics for Dengue: Recommendations for Design and Conduct of Early-Phase Clinical Trials
- Assessing dengue vaccination impact: Model challenges and future directions
- Glucocorticosteroids as Dengue Therapeutics: Resolving Clinical Observations With a Primary Human Macrophage Model Reply
- The pathogenesis of dengue
- CURRENT CONCEPTS Dengue
- Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza